News

Last week’s release of the ‘Australian Universities Census on Staff Wellbeing’ delivered headline results and a sector-wide ranking of universities, prompting calls for action to address widespread concerns. Yet the full story remains out of reach.

As part of the launch of Newcastle Art Gallery’s major reopening exhibition Iconic, Loved, Unexpected, a spatial exhibition in Gallery 10 Narrating Return will open at Newcastle Art Gallery on 27 February.

Two academics from the University of Newcastle have been recognised for their innovative and creative teaching styles at the Australian Awards for University Teaching (AAUT).

Giving primary-school students a chance to teach and lead their younger peers not only strengthens their leadership skills, but also improves wellbeing, classroom engagement and student confidence, a new Australian study has shown.

Lasting policy reforms, almost always, have difficult beginnings. Think Medicare, the Superannuation Guarantee, or the National Disability Insurance Scheme. They have proven transformative for so many Australians. Yet all three measures weathered early criticism over their impact on social equity, wage pressure and increased public spending.

A new art exhibition has emerged from a four‑year study led by University of Newcastle researcher Associate Professor Hedda Askland, exploring how the Hunter Valley can navigate its post‑mining future.

From taking apart video game consoles as a child, to winning software development competitions in school, University of Newcastle Computer Science student Saihajleen Kaur has always dreamt of being behind the scenes of computer tech development.

New science has revealed some of the Gwydir Wetlands’ iconic coolabahs and river red gums are up to 500 years old.

Hunter Medical Research Institute (HMRI) has unveiled a major upgrade to imaging capabilities with the installation of a new Siemens Healthineers MAGNETOM Cima.X Fit MRI scanner at the Hunter Medical Research Institute Imaging Centre, strengthening the region's capacity for world-class medical research.

Researchers are preparing for the arrival of a new state‑of‑the‑art instrument that will accelerate studies into some of the most aggressive cancers.

Popular GLP-1 and GIP medications, such as semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro) and liraglutide (Saxenda) are changing the way obesity and type 2 diabetes are viewed and treated.

Technology created at The University of Queensland, in collaboration with Newcastle researchers, could improve the odds of surviving brain cancer and change how we treat a range of neurological conditions.